Quantcast
Channel: CPRX
Browsing all 11 articles
Browse latest View live

Investor Report from BestOtc.com For Monday Nov 29th - CPRX, SAVW ZLCS, HIRU,...

___Tags: hiruZLCSLED lightingnasdaq:cprxHMPRNASDAQ:HMPRNASDAQ:ZLCSZalicusveterinary productschinese medicinedietary herbal supplementsHIRU.PKJiangxi Shaungshi PharmaceuticalShaungshi AHPXiang Ling...

View Article



Image may be NSFW.
Clik here to view.

(WWON, CPRX, CLNO, DLIA) Stock Report from PennyOTCStock.com

Cleantech Transit, Inc. (CLNO)Tags: CPRXCLNOWWONDLIA

View Article

(NYNY, CLNO, MVIS, CPRX) Noticeable Stocks by PennyOTCStock.com

Cleantech Transit, Inc. (CLNO)Tags: MVISNYNYCPRXCLNO

View Article

(SABA, ENZ, CLNO, TIII, CPRX, XATA) Stock in Action by DrStockPick.com

Saba Announces First Quarter Fiscal Year 2012 ResultsTotal quarterly billings up 18% with cloud billings growing 81% year-over-yearCloud revenue grew 59% year-over-yearSubscription revenue up 26%...

View Article

(DYSL, CLNO, CPRX, CERP) Stock Report from CRWEWallStreet.com

Tags: CERPCPRXCLNODYSL

View Article


(CPRX, MOVE, GBLHF, CTHR) Featured Stock by Stock-PR.com

Stock-PR ReportingFREE Daily Stock Alerts From Stock-PR.comTags: MoveCTHRCPRXGBLHF

View Article

Catalyst Pharmaceutical Partners, Inc recently showed an Exceptional Trade -...

Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX) witnessed volume of 981,486.00 shares during last trade however it holds an average trading capacity of 67,958.00 shares. CPRX last trade opened at...

View Article

(CPRX, UTI, CLNO, BGS, HIL) Stock Updates by BestOtc.com

Tags: bgsHILCPRXCLNOUTi

View Article


Catalyst Pharmaceutical Partners (CPRX) - PennyOmega.com Stock to Watch

CPRX, Catalyst Pharmaceutical Partners, Inc.Tags: nasdaq:cprxCPRXCatalyst-PharmaceuticalCPP-115hypsarrhythmiaInfantile spasmsmental retardationmyoclonic seizures

View Article


(SGI, CPRX, LHCG, CLNO, RPRX) Stock to Watch by CRWESelect.com

Tags: LHCGCPRXCLNOSGIRPRX

View Article

(CPRX, GBLHF, CTIC, ABIO) Stock Updates by DoubleInStocks.com

Catalyst Pharmaceutical Partners Inc. (Nasdaq:CPRX) announced that its investigational drug, CPP-115, a novel GABA aminotransferase inhibitor, has been designated as a Fast Track development program...

View Article
Browsing all 11 articles
Browse latest View live




Latest Images